Publication | Closed Access
Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea
37
Citations
24
References
2022
Year
The sex- and age-standardized prevalence of advanced fibrosis was 3.0% (range: 2.6-4.6%) in subjects with MAFLD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1